logo
Volume 2, Issue 4 (December 2013)                   J Emerg Health Care 2013, 2(4): 0-0 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Alawamreh T O, sami Abudayyeh R A, Qabha A H, Ismael M J, Megbel O K, Alkhaldi H. KETOFOL FOR MANAGEMENT OF CATHETER RELATED BLADDER DISCOMFORT. OUR EXPERIENCE AT PRINCE HUSSEIN UROLOGICAL CENTER. J Emerg Health Care 2013; 2 (4)
URL: http://intjmi.com/article-1-52-en.html
Department of anesthesiology, intensive care and pain management, KHMC, AMMAN, JORDAN
Abstract:   (9445 Views)
Our prospective, randomized and double blind study included 208 subjects, of both sexes, aged 27-49 years, classed I by the American society of anesthesiologists and assigned for different types of elective urological surgical procedures, having an 18 Fr Foleys catheter inserted intraoperatively, at Prince Hussein center, King Hussein medical center, Amman, Jordan, during the period Jan 2011-Jan 2013.Patients complaining of 0h postoperative catheter related bladder discomfort were divided into two groups. Group I (n=104) received intravenous Ketofol (mixture of ketamine 10mg (1ml) with propofol 10 mg (1ml) and group II (n=104) received intravenous 2ml normal saline. Catheter related bladder discomfort intensity was scored as mild, moderate and severe. Management was followed up at postoperative ½ and 1h intervals. Ketofol decreased significantly the intensity and frequency of catheter related bladder discomfort at ½ and 1 postoperative intervals (P<0.05). Intravenous Ketofol (10 mg propofol with 10 mg ketamine) is a potent management for decreasing the intensity and frequency of postoperative catheter related bladder discomfort.
Full-Text [PDF 205 kb]   (2735 Downloads)    
Type of Study: Research | Subject: General

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.